Clinical Trial Update: The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Efsubaglutide Alfa Injection in obesity/overweight subjects, indicating Phase 2/3 trials are active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Efsubaglutide Alfa Injection (Efsubaglutide Alfa)

Snippet

Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | Conditions: Obesity and Overweight | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING